We found that HDGF KO significantly intensifies the pro-apoptosis effects of niraparib in HCT116 and HT29 cells (Figure 5C), clearly demonstrating that HDGF KO increases CRC cell sensitivity to PARP inhibitors. This evidence concerns the gene HDGF and colorectal carcinoma.